RONAPREVE
300MG+300MG INJ/INF SOL 1X2,5ML+1X2,5ML
| SÚKL code | 0255265 |
|---|---|
| Name of the product | RONAPREVE |
| _MA_MEDICATION_DETAIL_INFO_MED_NAME i | RONAPREVE |
| Supplement | 300MG+300MG INJ/INF SOL 1X2,5ML+1X2,5ML |
| Strenght | 300MG+300MG |
| Pharmaceutical form | Solution for injection/infusion |
| Package | 1X2,5ML+1X2,5ML |
| Route | Subcutaneus/intravenous use |
| Wrap type | Vial |
| Legal status | na lékařský předpis |
| Active substance |
CASIRIVIMAB (CASIRIVIMABUM) IMDEVIMAB (IMDEVIMABUM) |
| ATC group | J06BD07 |
| ATC group name | KASIRIVIMAB A IMDEVIMAB |
Marketing authorisation information
| Registration Number | EU/1/21/1601/001 |
|---|---|
| Type of MA | centralised without orphans |
| MA status | R - active MA/authorised medicinal product |
| MA Holder | Roche Registration GmbH, Grenzach-Wyhlen |
| MA Holder country | NĚMECKO |
cz